Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

5.

Cdk inhibitory nucleoside analogs prevent transcription from viral genomes.

Schang LM, Coccaro E, Lacasse JJ.

Nucleosides Nucleotides Nucleic Acids. 2005;24(5-7):829-37. Review.

PMID:
16248044
7.

Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication.

Schang LM.

Biochim Biophys Acta. 2004 Mar 11;1697(1-2):197-209. Review.

PMID:
15023361
8.
9.

Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity.

Evers DL, Breitenbach JM, Borysko KZ, Townsend LB, Drach JC.

Antimicrob Agents Chemother. 2002 Aug;46(8):2470-6.

10.
11.

Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.

Holcakova J, Muller P, Tomasec P, Hrstka R, Nekulova M, Krystof V, Strnad M, Wilkinson GW, Vojtesek B.

PLoS One. 2014 Feb 21;9(2):e89228. doi: 10.1371/journal.pone.0089228. eCollection 2014.

12.

Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics.

Pumfery A, de la Fuente C, Berro R, Nekhai S, Kashanchi F, Chao SH.

Curr Pharm Des. 2006;12(16):1949-61. Review.

PMID:
16787240
13.

Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity.

Habran L, Bontems S, Di Valentin E, Sadzot-Delvaux C, Piette J.

J Biol Chem. 2005 Aug 12;280(32):29135-43. Epub 2005 Jun 13.

14.

Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFb.

Guo L, Wu WJ, Liu LD, Wang LC, Zhang Y, Wu LQ, Guan Y, Li QH.

PLoS One. 2012;7(9):e45749. doi: 10.1371/journal.pone.0045749. Epub 2012 Sep 24.

17.

Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs.

Schang LM, St Vincent MR, Lacasse JJ.

Antivir Chem Chemother. 2006;17(6):293-320. Review.

PMID:
17249245
18.

Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter.

Kushnir AS, Davido DJ, Schaffer PA.

J Virol. 2010 Jan;84(1):188-200. doi: 10.1128/JVI.01377-09.

19.

Cyclin-dependent kinases as cellular targets for antiviral drugs.

Schang LM.

J Antimicrob Chemother. 2002 Dec;50(6):779-92. Review.

PMID:
12460995
20.

Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs.

Schang LM.

Curr Drug Targets Infect Disord. 2005 Mar;5(1):29-37. Review.

PMID:
15777196

Supplemental Content

Support Center